Christopher de Souza is a Director at Broadview Ventures in Boston. He started his pharmaceutical career at Novartis as a senior scientist in the Metabolic and Cardiovascular Diseases group and then Director of Strategic Alliances. After Novartis, Christopher was VP of Business Development at SkyePharma US and also founded a business development consulting practice.
Dr. de Souza received an MBA from Rutgers University and a Ph.D. in physiology from Louisiana State University. He completed his post-doctoral training at “The Upjohn Company” and the Joslin Diabetes Center/Harvard Medical School.
Current role
Board Member at Husqvarna Group
Board Member at Husqvarna Group
Board Member at Husqvarna Group
Board Member at Chartered Professional Accountants of Ontario
Board Member at Chartered Professional Accountants of Ontario